Health & Wellbeing
2021 Detailed Description of Preventive Services -C2760R10 .pdf
Search Results
Displaying 3761 - 3770 of 4274 results
Provider
Topical NSAIDs - Medicaid
Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Topical Corticosteroids - Medicaid
Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Vowst (fecal microbiota spores, live-brpk) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Vowst (fecal microbiota spores, live-brpk) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Winlevi (clascoterone) - Commercial
Prior Authorization
Program effective Date: Dec 01, 2025
Provider
Pancreatic Enzymes - Commercial
Step Therapy
Program effective Date: Jun 01, 2025
Provider
Lyrica (pregabalin) Savella (milnacipran) - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jun 01, 2025
Provider
Low Molecular Weight Heparins (LMWH) and Arixtra - Commercial
Quantity Limit
Program effective Date: Jul 01, 2025